http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1127078-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87913ce8a05bad3cbd18ddeb65a67dbd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-962
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
filingDate 1979-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1982-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be46668e49a3e99f84f52c507000a917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9ceb6a13a75533587ab44b83362ff5
publicationDate 1982-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1127078-A
titleOfInvention Mice ascitic fluid (euglobulin) in immunoassay
abstract ABSTRACT OF THE DISCLOSURE A liquid, particularly but not exclusively a liquid of human origin such as blood serum or urine, is immunoassayed for antibodies, antigens or antibody: antigen complexes, using as a reagent in the analysis an active fraction from mouse ascitic fluid. This active fraction is a euglobulin and has the ability, like human C1q, to combine with antibody:antigen complexes but not with free antibody or antigen. Unlike human C1q, however, it remains active at high pH's and its activity is not destroyed by 0.1M putrescine or 0.1M hydrazine, so analyses on human body fluids can be carried out at high pH's or in the presence of putrescine and hydrazine, without interference from endogenous human C1q. The active fraction is a very broadly applicable reagent in immunoassays and particularly useful in techniques involving agglutination of latex particles.
priorityDate 1978-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5F4BTH8
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1045
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID767827
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID716
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M7Q5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489853
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1P6E1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410576485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10844611
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527

Total number of triples: 33.